Evofem Biosciences (EVFM) EBITDA (2014 - 2026)
Evofem Biosciences (EVFM) reported EBITDA of -$2.47 million for Q2 2026, compared with -$1.14 million a year earlier.
Powered by 
Analysis
Evofem Biosciences (EVFM) EBITDA (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Evofem Biosciences' EBITDA came in at -$2.44 million; for FY2025, it was $3.89 million.
- By year, EBITDA came in at -$7.03 million in FY2024, -$17.37 million in FY2023, -$83.11 million in FY2022 and -$165.78 million in FY2021.
- Five-year quarterly EBITDA spans a low of -$43.1 million in Q3 2021 and a high of $3.44 million in Q4 2025.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$4.47 million (Q1 2026), $3.44 million (Q4 2025) and $1.06 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.71 Bn | 1,140.30 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 642.13 Bn | 560.65 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 501.64 Bn | 474.75 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 375.66 Bn | 330.04 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 302.79 Bn | 266.78 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 268.68 Bn | 242.37 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 242.43 Bn | 197.83 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 193.69 Bn | 167.89 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 172.47 Bn | 119.12 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Evofem Biosciences | 1.33 Mn | 1.33 Mn | 2.12 Mn | -2.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.47 Mn |
| Mar 31, 2026 | -4.47 Mn |
| Dec 31, 2025 | 3.44 Mn |
| Sep 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | -1.14 Mn |
| Mar 31, 2025 | 556,000.00 |
| Dec 31, 2024 | -680,000.00 |
| Sep 30, 2024 | -2.13 Mn |
| Jun 30, 2024 | -1.38 Mn |
| Mar 31, 2024 | -2.83 Mn |
| Dec 31, 2023 | -3.36 Mn |
| Sep 30, 2023 | -3.52 Mn |
| Jun 30, 2023 | -7.16 Mn |
| Mar 31, 2023 | -3.33 Mn |
| Dec 31, 2022 | -11.80 Mn |
| Sep 30, 2022 | -18.47 Mn |
| Jun 30, 2022 | -24.17 Mn |
| Mar 31, 2022 | -28.66 Mn |
| Dec 31, 2021 | -37.13 Mn |
| Sep 30, 2021 | -43.10 Mn |
API Access
Evofem Biosciences EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();